19 Oct, 2024 @ 09:00
5 mins read

Health alert on Spain’s Costa del Sol after expat is accused of ‘making millions’ peddling illegal cancer treatments

A MARBELLA businessman has been accused of peddling illegal cancer treatments to hundreds of patients – netting him millions of euros in the process.

In 2019, the Junta de Andalucia received a report accusing Immucura Med SL of using advanced therapy drugs illegally. 

READ MORE: Cancer becomes leading cause of death in Spain for first time according to 2023 mortality figures

The company claimed to help terminally ill patients fight cancer.
Photo: Immucura

The Spanish Medicines Agency (AEMPs) also reported the company for offering dendritic cell therapy, a cancer treatment not currently authorised in Spain. 

Johannes Schumacher, Founder and Managing Director of Immucura, was ordered to cease offering the treatment and received a hefty fine for ‘carrying out health procedures without authorisation.’ 

Schumacher has no evident experience in the medical field.
Photo: Immucura

Despite this, an international group of investigative journalists claims the German-owned company has continued offering treatments into 2024. 

The consortium was made up of El Pais, German TV channel ZDF, Austrian newspaper Der Standard and Belgian newspaper De Tijd. 

They found that Schumacher had been offering dendritic cell therapy for almost a decade, working with hundreds of terminally ill patients all over Europe and raking in millions of euros. 

Dendritic cell therapy uses your own immune cells to fight diseases, especially cancer. 

A special type of immune cell, dendritic cells help the immune system recognise and attack cancer cells. 

In dendritic cell therapy, doctors take a blood sample and extract the dendritic cells. These are then ‘trained’ in a lab to recognise cancer cells by exposing them to small parts of the tumour. 

They are subsequently injected back into the patient, where they help activate the immune system to target and destroy cancer cells.

Currently, the only commercial licence for dendritic cell therapy is available in the US. 

Many studies are still ongoing into the effectiveness of the treatment and it is often only available via clinical trials. 

READ MORE: Spain to roll out its first ever cancer jab that will reduce treatments from one hour to just seven minutes

Immucura plasters claims about their cancer fighting abilities all over social media.
Photo: Immucura

Schumacher originally worked in investment banking, managing funds in the Cayman Islands and even claims to have advised the Russian government. 

However, despite not having medical qualifications, he has published a book lauding the positive effects of dendritic cell therapy for cancer patients.

Schumacher’s tell-all book is available on Amazon for around €15
Photo: Amazon

The book promises to ‘help you understand how you have the power to overcome cancer’, with recommendations from grateful patients stating ‘thanks to Immucura I overcome a brain tumor.’

In 2022, Immucura was again reported to the Junta, incurring more fines. 

Although the company claims they no longer operate in Spain, the newspaper De Tijd found that a Belgian patient received a phone call from Spain as well as paperwork sent from Marbella.

Despite Immacura’s stating ‘their services are not available in Spain’, you can easily access the website, where there is a job advert for an English speaking ‘Health Coordinator’ in Marbella. 

On June 26 this year, the Marbella Prosecutor’s Office announced they were investigating Immucura Med SL for fraud and crimes against public health. 

READ MORE: Skin cancer rates are surging on Spain’s Costa del Sol, warn health experts

Schumacher happily posing with an award.
Photo: Immucura

The company has treated over 1,000 people across six European countries, according to Airomedical, a treatment search engine. 

Despite job titles including ‘Health Coordinator’, potential employees must only have sales experience, with health related experience a ‘plus’.

The company is still advertising for jobs in Marbella despite the Junta’s closure order.
Photo: Immucura

According to an ex-employee: “What we did in Marbella was all commercial. We contacted people that left their details on the website to sell them the treatment. One person had been a shop assistant, another a musician, people from all backgrounds, it was rare that people had knowledge of biology or medicine.” 

Initially, the treatment was offered for around €40,000. 

“Immucura Med SL has not had any health centres, services or establishments authorised by the Junta de Andalucia,” said the Junta in a statement. 

Another ex-employee told the investigative journalists: “They were just intermediaries without any type of medical knowledge or ability to offer treatment, they just sold patients a treatment for four times the price they bought it for,” he explained. 

The employee left Immucura after seeing it was not a ‘legitimate clinic.’ 

When Schumacher responded to questions from the journalists investigating the company he said: “We do not require permission to work in countries where we treat patients because our role is to mediate between patients, laboratories and clinics…they have the appropriate licenses.”

READ MORE: Drinking alcohol is the leading cause of liver cancer even if you only do it on the weekends, warn scientists in Spain

Schumacher has refused to name any of the other clinics involved in the scandal.
Photo: Immucura

He refused to name any of the laboratories or clinics Immucura works with due to ‘patient confidentiality.’ 

Although the company claims to work with ‘highly qualified’ specialists, El Pais claims it is ‘difficult to find people with a cancer related career.’

Even the Medical Director, Riadh Ben Sghaier MD, does not include any cancer related work on his public CV but he has worked in the medical field since 2003.

On LinkedIn, he states he worked at Immucura Marbella from August 2022 until June 2023, when he moved to Benalmadena based Sonic Health. 

Though Schumacher did not reveal which clinics he worked with, the Junta’s 2019 investigation resulted in the closure of nearby Clinica El Campanario, Calahonda. 

According to an ex-employee consulted by the European journalists, this was one of Immucura’s key partners. 

Despite patients travelling to Gibraltar with Schumacher to receive treatment and advertising services in Gibraltar, the Gibraltarian authorities state there are ‘no medical clinics which have requested a license to carry out dendritic cell treatments.’

Additionally, the German journalists involved in the investigation could not identify the ‘supersecret lab in Germany’ many sales representatives speak about when offering dendritic cell treatment. 

The German authorities state there are only four laboratories which work with dendritic cells in the country and all of them denied working with Immucura. 

Patients say they have received packages from a laboratory in Ulm, a city in southern Germany best known for being the birthplace of Albert Einstein. 

However, the owner denied having worked with Schumacher and claimed he did not know how Immucura had procured their signature. 

They also recognised never having worked with dendritic cells or had a licence to do so. 

Haematologist Felipe Prosper, director of the Advanced Therapies Unit at the Clinica Universidad de Navarra, has participated in clinical trials to test dendritic cells. 

Although it is a promising treatment, he states: “We don’t yet know whether it can be used in combination or as a single therapy. We are looking for the best options.”

READ MORE: Incredible new SALIVA test for breast cancer will diagnose patients in less than five SECONDS

Despite not being licensed for commercial use anywhere but the USA, Immucura continues to tout dendritic cell therapy as a cure for cancer.
Photo: Immucura

Dendritic cell therapy is often praised for its lack of side effects.  

However, El Pais highlights Immucura’s ‘questionable’ practices, including sending cells by post, a lack of supervision by an oncologist and a lack of follow ups. 

They also highlight that dendritic cell therapy is still in clinical trial phases and not licensed for use in many countries. 

Usually, when a patient engages in such experimental treatment, they do not have to pay the fees. 

Immucura’s website states patients are made aware the treatment is ‘still in the process of scientific research’ but at the same time claims their ‘results are based on science’ and the treatment is ‘natural, safer and cheaper.’ 

In 2022, a company was founded in Dublin under the name Immucura Limited.

The new venture was incorporated through Goodspeed Business Solutions, a Spanish company founded by Schumacher in 2021. 

The German businessman also established Immunyo in June 2023, an Ireland based treatment centre offering dendritic cell therapies. 

However, this is not yet legal in Ireland. 

The review of a Swedish man who lost his wife to cancer despite Immucura’s treatment, summarises the desperation and hope fuelling the business: “I have no regrets. If I had helped, it would have been worth every penny.” 

The Olive Press has contacted Immucura for comment but received no response. 

READ MORE: Revealed: How the Mediterranean diet enjoyed in Spain could prevent several cancers

Yzabelle Bostyn

Yzabelle Bostyn is an NCTJ trained journalist who started her journalistic career at the Olive Press in 2023.
Before moving to Spain, she studied for a BA in English Literature and Hispanic Studies at the University of Sheffield.
After graduating she moved to the university’s journalism department, one of the best in the UK.
Throughout the past few years, she has taken on many roles including social media marketing, copywriting and radio presenting.
She then took a year out to travel Latin America, scaling volcanoes in Guatemala and swimming with sharks in Belize.
Then, she came to the Olive Press last year where she has honed her travel writing skills and reported on many fantastic experiences such as the Al Andalus luxury train.
She has also undertaken many investigations, looking into complex issues like Spain’s rental crisis and rising cancer rates.
Always willing to help, she has exposed many frauds and scams, working alongside victims to achieve justice.
She is most proud of her work on Nolotil, a drug linked to the deaths of many Brits in Spain.
A campaign launched by Yzabelle has received considerable support and her coverage has been by the UK and Spanish media alike.
Her writing has featured on many UK news outlets from the Sun to the Mail Online, who contracted her to report for them in Tenerife on growing tourism issues.
Recently, she has appeared on Times Radio covering deadly flooding in Valencia.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Paul Blanchard
Previous Story

BREAKING: British ‘undercover agent who spied for Spanish spooks’ ordered to be extradited to Spain to face money laundering charges

Next Story

Spain’s southern regions have the highest risk of poverty in Europe – and tourism mecca Andalucia is the worst off

Latest from Crime & Law

Go toTop

More From The Olive Press